Insmed Incorporated
INSMNASDAQHealthcare● Active
$94.17
$-0.05(-0.05%)
Market Cap$20.4B
P/E Ratio—
52W High$212.75
52W Low$86
Insmed Incorporated（INSM）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · INSM · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($1.28B) | ($0.91B) | ($0.75B) | ($0.48B) | ($0.43B) |
| Depreciation & Amort. | $0.02B | $0.01B | $0.01B | $0.01B | $0.01B |
| Stock-Based Comp. | $0.15B | $0.10B | $0.07B | $0.06B | $0.05B |
| Change in Working Capital | ($0.08B) | ($0.00B) | ($0.04B) | $0.01B | ($0.06B) |
| Net Cash from Operations | ($0.94B) | ($0.68B) | ($0.54B) | ($0.40B) | ($0.36B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.03B) | ($0.02B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Purchases of Investments | ($2.09B) | ($1.58B) | ($0.59B) | ($0.10B) | ($0.05B) |
| Sales of Investments | $2.09B | $1.02B | $0.38B | $0.07B | $0.06B |
| Net Cash from Investing | ($0.06B) | ($0.58B) | ($0.22B) | ($0.03B) | ($0.06B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.00B) | $0.15B | ($0.00B) | $0.35B | $0.34B |
| Net Cash from Financing | $0.95B | $1.34B | $0.17B | $0.79B | $0.61B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.97B) | ($0.71B) | ($0.55B) | ($0.41B) | ($0.37B) |
| FCF Margin %(computed) | -159.55% | -194.06% | -180.05% | -167.23% | -196.64% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Insmed Incorporated
关于Insmed Incorporated（INSM）现金流量表
Insmed Incorporated 2025财年经营活动现金流($0.94B)，自由现金流($0.97B)（FCF利润率-159.55%），资本支出($0.03B)。
常见问题
INSM · 4 问Insmed Incorporated 2025财年自由现金流($0.97B)，同比down37.1%。
INSM free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10